205 related articles for article (PubMed ID: 21625590)
1. Viral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaques.
Vanderford TH; Bleckwehl C; Engram JC; Dunham RM; Klatt NR; Feinberg MB; Garber DA; Betts MR; Silvestri G
PLoS Pathog; 2011 May; 7(5):e1002048. PubMed ID: 21625590
[TBL] [Abstract][Full Text] [Related]
2. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
Mothé BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI
J Virol; 2002 Jan; 76(2):875-84. PubMed ID: 11752176
[TBL] [Abstract][Full Text] [Related]
3. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
[TBL] [Abstract][Full Text] [Related]
4. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
[TBL] [Abstract][Full Text] [Related]
5. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.
Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ
J Virol; 2014 Dec; 88(24):14310-25. PubMed ID: 25275134
[TBL] [Abstract][Full Text] [Related]
6. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
[TBL] [Abstract][Full Text] [Related]
7. Rhesus Cytomegalovirus-Specific CD8
Rosen BC; Pedreño-Lopez N; Ricciardi MJ; Reed JS; Sacha JB; Rakasz EG; Watkins DI
Front Immunol; 2020; 11():1960. PubMed ID: 32922404
[TBL] [Abstract][Full Text] [Related]
8. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
9. The Mamu B 17-restricted SIV Nef IW9 to TW9 mutation abrogates correct epitope processing and presentation without loss of replicative fitness.
Minang JT; Trivett MT; Coren LV; Barsov EV; Piatak M; Chertov O; Chertova E; Ott DE; Ohlen C
Virology; 2008 May; 375(1):307-14. PubMed ID: 18328525
[TBL] [Abstract][Full Text] [Related]
10. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
[TBL] [Abstract][Full Text] [Related]
11. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
O'Connor DH; Allen TM; Vogel TU; Jing P; DeSouza IP; Dodds E; Dunphy EJ; Melsaether C; Mothé B; Yamamoto H; Horton H; Wilson N; Hughes AL; Watkins DI
Nat Med; 2002 May; 8(5):493-9. PubMed ID: 11984594
[TBL] [Abstract][Full Text] [Related]
12. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
[TBL] [Abstract][Full Text] [Related]
13. Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.
Connick E; Folkvord JM; Lind KT; Rakasz EG; Miles B; Wilson NA; Santiago ML; Schmitt K; Stephens EB; Kim HO; Wagstaff R; Li S; Abdelaal HM; Kemp N; Watkins DI; MaWhinney S; Skinner PJ
J Immunol; 2014 Dec; 193(11):5613-25. PubMed ID: 25362178
[TBL] [Abstract][Full Text] [Related]
14. Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.
Ishii H; Kawada M; Tsukamoto T; Yamamoto H; Matsuoka S; Shiino T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Naruse TK; Kimura A; Takiguchi M; Matano T
J Virol; 2012 Jan; 86(2):738-45. PubMed ID: 22072784
[TBL] [Abstract][Full Text] [Related]
15. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
[TBL] [Abstract][Full Text] [Related]
16. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial.
Kawada M; Tsukamoto T; Yamamoto H; Iwamoto N; Kurihara K; Takeda A; Moriya C; Takeuchi H; Akari H; Matano T
J Virol; 2008 Oct; 82(20):10199-206. PubMed ID: 18667518
[TBL] [Abstract][Full Text] [Related]
17. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.
Friedrich TC; McDermott AB; Reynolds MR; Piaskowski S; Fuenger S; De Souza IP; Rudersdorf R; Cullen C; Yant LJ; Vojnov L; Stephany J; Martin S; O'Connor DH; Wilson N; Watkins DI
J Virol; 2004 Sep; 78(18):10064-73. PubMed ID: 15331739
[TBL] [Abstract][Full Text] [Related]
18. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
19. Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta).
Wilson LA; Murphey-Corb M; Martin LN; Harrison RM; Ratterree MS; Bohm RP
J Med Primatol; 2000 Aug; 29(3-4):173-81. PubMed ID: 11085580
[TBL] [Abstract][Full Text] [Related]
20. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
